MedRegen has successfully completed the phase I study in healthy volunteers. MRG-001 has demonstrated to be safe across all dosages and effective in the mobilization of stem cells.
MedRegen has successfully completed the phase I study in healthy volunteers. MRG-001 has demonstrated to be safe across all dosages and effective in the mobilization of stem cells.